Literature DB >> 10027032

In vitro effects of propofol on blood coagulability and fibrinolysis by the use of thromboelastograph technique.

S Kohro1, M Yamakage, T Omote, A Namiki.   

Abstract

BACKGROUND: To investigate the in vitro effects of propofol on blood coagulability and fibrinolysis by the use of thromboelastograph (TEG) technique.
METHODS: The blood samples, obtained from 14 healthy volunteers, were divided into two groups: propofol (n = 7) and intralipid (n = 7), and 360 microliters volumes of whole blood were incubated with 2 microliters of 1% propofol and with its solvent intralipid, respectively. The incubated sample was then used for TEG measurements.
RESULTS: The maximum amplitude (MA), which reflects coagulability, in the intralipid group significantly increased by about 7% and 16% compared to the control and propofol groups, respectively (P < 0.05), whereas the MA in the propofol group did not change. The fibrinolytic rate (FR) in the propofol group significantly increased by about 170% and 210% compared to the control and intralipid groups, respectively (P < 0.05), whereas the FR in the intralipid group did not change.
CONCLUSIONS: Propofol, per se, has at the concentration of 55.6 micrograms.ml-1 an in vitro accelerative effect on blood fibrinolysis detected by TEG.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10027032     DOI: 10.1034/j.1399-6576.1999.430217.x

Source DB:  PubMed          Journal:  Acta Anaesthesiol Scand        ISSN: 0001-5172            Impact factor:   2.105


  2 in total

1.  Bleeding diathesis is associated with an A15T heterozygous mutation in exon 2 of the plasminogen activator inhibitor type 1.

Authors:  Jerzy Jankun; Ewa Skrzypczak-Jankun
Journal:  Exp Ther Med       Date:  2010-07-01       Impact factor: 2.447

2.  Application of long-acting VLHL PAI-1 during sutureless partial nephrectomy in mice reduces bleeding.

Authors:  Khaled Shahrour; Rick Keck; Jerzy Jankun
Journal:  Biomed Res Int       Date:  2015-03-26       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.